CAMELOT Consulting Group introduces new patient-centered blockchain application for pharma and healthcare
Mannheim, Montreux, 04/09/2018 – Innovative cell therapies are often the last but most promising form of treatment for cancer patients. However, such procedures are highly complex and involve the exchange of sensitive patient data between many stakeholders. With Hypertrust X-Chain, the CAMELOT Consulting Group offers a blockchain-based solution that ensures the highest level of security for the storage and sharing of patient data for autologous extracorporeal cell treatment. This solution will be presented for the first time at the LogiPharma conference from April 10-12 in Montreux to a wide audience of experts.
“Since highly innovative extracorporeal cell therapies are often the last hope for many patients, there is no room for error in the entire process. That is why we have come up with a digital application that not only ensures maximum data-sharing and data-storage security, but also focuses on the patient,” said Dr. Josef Packowski, CEO of CAMELOT Consulting Group, with regard to the motivation to develop the innovative Hypertrust X-Chain application. “As consulting specialists for the digitalization of pharmaceutical and healthcare value chains, the need here was clear to us,” continued Josef Packowski.
Many stakeholders and analog data transfer
With extracorporeal cell therapies, cells are removed from the patient, then deep-frozen for transport to the pharmaceutical manufacturer, where they are processed in an elaborate, multi-stage process before being refrozen and sent back to be reimplanted in the patient on-site. Many different stakeholders, such as the treating clinic, the cell collection center, logistics service providers and pharmaceutical companies are involved in this process. Most of the important data continues to be transmitted in analog form and then rerecorded over the course of the process. The risk of erroneous data and data abuse is thus extremely high.
How Hypertrust X-Chain works
In the application developed by CAMELOT, the focus is on the patient. A closed-loop supply chain approach ensures that there are no mistakes throughout the process: from collecting the cells, processing them, transporting them between the stakeholders, and returning the ‘right cells’ to the ‘right patients’. In accordance with legal data protection guidelines, the relevant patient data is made available to the stakeholders authorized for the therapy process on the basis of the blockchain technology by means of a decentralized data storage. All data transactions take place exclusively between verified participants and are immutably and consistently stored by means of encryption in the blockchain. In addition, Hypertrust X-Chain enables the flexible integration of partner systems, real-time temperature, location and quality controls as well as secure guarantees of origin. Combined with the appropriate hardware (Camelot Trusted Computing Appliances), it also ensures that decentrally stored private data actually remain private.